Novo Nordisk to launch new therapies in blood and growth disorders after success in diabetes and obesity
- Posted on March 6, 2025
- By Financial Express
- 1 Views
Novo Nordisk to launch new therapies in blood and growth disorders after success in diabetes and obesity
Martin Holst Lange, Executive Vice President, Development, Novo Nordisk, highlighted during the press briefing that their purpose is to address unmet needs in serious chronic disease and a holistic approach is necessary.
